Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glutathione S-transferase P/Tyrosine-protein kinase JAK1 (Homo sapiens (Human)) | BDBM257392 (US9493441, 1-3) | PDB UniProtKB/SwissProt DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 267 | n/a | n/a | n/a | n/a | n/a | 25 |
Merck Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ... | US Patent US9493441 (2016) BindingDB Entry DOI: 10.7270/Q22J69S2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Tyrosine-protein kinase JAK1 (Homo sapiens (Human)) | BDBM257405 (US9493441, 1-16) | PDB UniProtKB/SwissProt DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 19 | n/a | n/a | n/a | n/a | n/a | 25 |
Merck Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ... | US Patent US9493441 (2016) BindingDB Entry DOI: 10.7270/Q22J69S2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Tyrosine-protein kinase JAK1 (Homo sapiens (Human)) | BDBM257406 (US9493441, 1-17) | PDB UniProtKB/SwissProt DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 19 | n/a | n/a | n/a | n/a | n/a | 25 |
Merck Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ... | US Patent US9493441 (2016) BindingDB Entry DOI: 10.7270/Q22J69S2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Tyrosine-protein kinase JAK1 (Homo sapiens (Human)) | BDBM257408 (US9493441, 1-19) | PDB UniProtKB/SwissProt DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 31 | n/a | n/a | n/a | n/a | n/a | 25 |
Merck Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ... | US Patent US9493441 (2016) BindingDB Entry DOI: 10.7270/Q22J69S2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Tyrosine-protein kinase JAK1 (Homo sapiens (Human)) | BDBM257416 (US9493441, 3-3) | PDB UniProtKB/SwissProt DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | 25 |
Merck Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ... | US Patent US9493441 (2016) BindingDB Entry DOI: 10.7270/Q22J69S2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Tyrosine-protein kinase JAK1 (Homo sapiens (Human)) | BDBM257432 (US9493441, 4-16) | PDB UniProtKB/SwissProt DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 19 | n/a | n/a | n/a | n/a | n/a | 25 |
Merck Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ... | US Patent US9493441 (2016) BindingDB Entry DOI: 10.7270/Q22J69S2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Tyrosine-protein kinase JAK1 (Homo sapiens (Human)) | BDBM257446 (US9493441, 4-30) | PDB UniProtKB/SwissProt DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 15 | n/a | n/a | n/a | n/a | n/a | 25 |
Merck Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ... | US Patent US9493441 (2016) BindingDB Entry DOI: 10.7270/Q22J69S2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Tyrosine-protein kinase JAK1 (Homo sapiens (Human)) | BDBM257421 (BDBM257456 | US9493441, 4-5) | PDB UniProtKB/SwissProt DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 360 | n/a | n/a | n/a | n/a | n/a | 25 |
Merck Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ... | US Patent US9493441 (2016) BindingDB Entry DOI: 10.7270/Q22J69S2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Tyrosine-protein kinase JAK1 (Homo sapiens (Human)) | BDBM257483 (US9493441, 14-2) | PDB UniProtKB/SwissProt DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | 25 |
Merck Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ... | US Patent US9493441 (2016) BindingDB Entry DOI: 10.7270/Q22J69S2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Tyrosine-protein kinase JAK1 (Homo sapiens (Human)) | BDBM257495 (US9493441, 19-1) | PDB UniProtKB/SwissProt DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | 25 |
Merck Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ... | US Patent US9493441 (2016) BindingDB Entry DOI: 10.7270/Q22J69S2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Tyrosine-protein kinase JAK2 (Homo sapiens (Human)) | BDBM257397 (US9493441, 1-8) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 999 | n/a | n/a | n/a | n/a | n/a | 25 |
Merck Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ... | US Patent US9493441 (2016) BindingDB Entry DOI: 10.7270/Q22J69S2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Tyrosine-protein kinase JAK2 (Homo sapiens (Human)) | BDBM257416 (US9493441, 3-3) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 236 | n/a | n/a | n/a | n/a | n/a | 25 |
Merck Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ... | US Patent US9493441 (2016) BindingDB Entry DOI: 10.7270/Q22J69S2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Tyrosine-protein kinase JAK2 (Homo sapiens (Human)) | BDBM257418 (US9493441, 4-2) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | 25 |
Merck Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ... | US Patent US9493441 (2016) BindingDB Entry DOI: 10.7270/Q22J69S2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Tyrosine-protein kinase JAK2 (Homo sapiens (Human)) | BDBM257457 (US9493441, 6-3) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | 25 |
Merck Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ... | US Patent US9493441 (2016) BindingDB Entry DOI: 10.7270/Q22J69S2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Tyrosine-protein kinase JAK2 (Homo sapiens (Human)) | BDBM257391 (BDBM257486 | US9493441, 1-2) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 601 | n/a | n/a | n/a | n/a | n/a | 25 |
Merck Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ... | US Patent US9493441 (2016) BindingDB Entry DOI: 10.7270/Q22J69S2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Tyrosine-protein kinase JAK2 (Homo sapiens (Human)) | BDBM257490 (US9493441, 17-2) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 469 | n/a | n/a | n/a | n/a | n/a | 25 |
Merck Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ... | US Patent US9493441 (2016) BindingDB Entry DOI: 10.7270/Q22J69S2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Tyrosine-protein kinase JAK2 (Homo sapiens (Human)) | BDBM257491 (US9493441, 17-3) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 79 | n/a | n/a | n/a | n/a | n/a | 25 |
Merck Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ... | US Patent US9493441 (2016) BindingDB Entry DOI: 10.7270/Q22J69S2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Tyrosine-protein kinase JAK2 (Homo sapiens (Human)) | BDBM257492 (US9493441, 17-4) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 16 | n/a | n/a | n/a | n/a | n/a | 25 |
Merck Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ... | US Patent US9493441 (2016) BindingDB Entry DOI: 10.7270/Q22J69S2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Tyrosine-protein kinase JAK1 (Homo sapiens (Human)) | BDBM257427 (US9493441, 4-11) | PDB UniProtKB/SwissProt DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 9 | n/a | n/a | n/a | n/a | n/a | 25 |
Merck Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ... | US Patent US9493441 (2016) BindingDB Entry DOI: 10.7270/Q22J69S2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Tyrosine-protein kinase JAK1 (Homo sapiens (Human)) | BDBM257447 (US9493441, 4-31) | PDB UniProtKB/SwissProt DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | 25 |
Merck Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ... | US Patent US9493441 (2016) BindingDB Entry DOI: 10.7270/Q22J69S2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Tyrosine-protein kinase JAK1 (Homo sapiens (Human)) | BDBM257451 (US9493441, 4-35) | PDB UniProtKB/SwissProt DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | 25 |
Merck Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ... | US Patent US9493441 (2016) BindingDB Entry DOI: 10.7270/Q22J69S2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Tyrosine-protein kinase JAK1 (Homo sapiens (Human)) | BDBM257459 (US9493441, 7) | PDB UniProtKB/SwissProt DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | 25 |
Merck Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ... | US Patent US9493441 (2016) BindingDB Entry DOI: 10.7270/Q22J69S2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Tyrosine-protein kinase JAK1 (Homo sapiens (Human)) | BDBM257461 (US9493441, 9) | PDB UniProtKB/SwissProt DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 59 | n/a | n/a | n/a | n/a | n/a | 25 |
Merck Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ... | US Patent US9493441 (2016) BindingDB Entry DOI: 10.7270/Q22J69S2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Tyrosine-protein kinase JAK1 (Homo sapiens (Human)) | BDBM257473 (US9493441, 11-11) | PDB UniProtKB/SwissProt DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 46 | n/a | n/a | n/a | n/a | n/a | 25 |
Merck Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ... | US Patent US9493441 (2016) BindingDB Entry DOI: 10.7270/Q22J69S2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Tyrosine-protein kinase JAK2 (Homo sapiens (Human)) | BDBM257407 (US9493441, 1-18) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 413 | n/a | n/a | n/a | n/a | n/a | 25 |
Merck Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ... | US Patent US9493441 (2016) BindingDB Entry DOI: 10.7270/Q22J69S2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Tyrosine-protein kinase JAK2 (Homo sapiens (Human)) | BDBM257421 (BDBM257456 | US9493441, 4-5) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.48E+3 | n/a | n/a | n/a | n/a | n/a | 25 |
Merck Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ... | US Patent US9493441 (2016) BindingDB Entry DOI: 10.7270/Q22J69S2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Tyrosine-protein kinase JAK2 (Homo sapiens (Human)) | BDBM257428 (US9493441, 4-12) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 66 | n/a | n/a | n/a | n/a | n/a | 25 |
Merck Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ... | US Patent US9493441 (2016) BindingDB Entry DOI: 10.7270/Q22J69S2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Tyrosine-protein kinase JAK2 (Homo sapiens (Human)) | BDBM257436 (US9493441, 4-20) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 87 | n/a | n/a | n/a | n/a | n/a | 25 |
Merck Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ... | US Patent US9493441 (2016) BindingDB Entry DOI: 10.7270/Q22J69S2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Tyrosine-protein kinase JAK2 (Homo sapiens (Human)) | BDBM257442 (US9493441, 4-26) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 277 | n/a | n/a | n/a | n/a | n/a | 25 |
Merck Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ... | US Patent US9493441 (2016) BindingDB Entry DOI: 10.7270/Q22J69S2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Tyrosine-protein kinase JAK2 (Homo sapiens (Human)) | BDBM257444 (US9493441, 4-28) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 75 | n/a | n/a | n/a | n/a | n/a | 25 |
Merck Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ... | US Patent US9493441 (2016) BindingDB Entry DOI: 10.7270/Q22J69S2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Tyrosine-protein kinase JAK2 (Homo sapiens (Human)) | BDBM257460 (US9493441, 8) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 34 | n/a | n/a | n/a | n/a | n/a | 25 |
Merck Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ... | US Patent US9493441 (2016) BindingDB Entry DOI: 10.7270/Q22J69S2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Tyrosine-protein kinase JAK2 (Homo sapiens (Human)) | BDBM257462 (US9493441, 10) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 45 | n/a | n/a | n/a | n/a | n/a | 25 |
Merck Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ... | US Patent US9493441 (2016) BindingDB Entry DOI: 10.7270/Q22J69S2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Tyrosine-protein kinase JAK1 (Homo sapiens (Human)) | BDBM257390 (US9493441, 1-1) | PDB UniProtKB/SwissProt DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | 25 |
Merck Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ... | US Patent US9493441 (2016) BindingDB Entry DOI: 10.7270/Q22J69S2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Tyrosine-protein kinase JAK1 (Homo sapiens (Human)) | BDBM257398 (US9493441, 1-9) | PDB UniProtKB/SwissProt DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 241 | n/a | n/a | n/a | n/a | n/a | 25 |
Merck Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ... | US Patent US9493441 (2016) BindingDB Entry DOI: 10.7270/Q22J69S2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Tyrosine-protein kinase JAK1 (Homo sapiens (Human)) | BDBM257411 (US9493441, 1-22) | PDB UniProtKB/SwissProt DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 32 | n/a | n/a | n/a | n/a | n/a | 25 |
Merck Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ... | US Patent US9493441 (2016) BindingDB Entry DOI: 10.7270/Q22J69S2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Tyrosine-protein kinase JAK1 (Homo sapiens (Human)) | BDBM257413 (US9493441, 2) | PDB UniProtKB/SwissProt DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 124 | n/a | n/a | n/a | n/a | n/a | 25 |
Merck Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ... | US Patent US9493441 (2016) BindingDB Entry DOI: 10.7270/Q22J69S2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Tyrosine-protein kinase JAK1 (Homo sapiens (Human)) | BDBM257422 (US9493441, 4-6) | PDB UniProtKB/SwissProt DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 33 | n/a | n/a | n/a | n/a | n/a | 25 |
Merck Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ... | US Patent US9493441 (2016) BindingDB Entry DOI: 10.7270/Q22J69S2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Tyrosine-protein kinase JAK1 (Homo sapiens (Human)) | BDBM257438 (US9493441, 4-22) | PDB UniProtKB/SwissProt DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | 25 |
Merck Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ... | US Patent US9493441 (2016) BindingDB Entry DOI: 10.7270/Q22J69S2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Tyrosine-protein kinase JAK1 (Homo sapiens (Human)) | BDBM257474 (US9493441, 11-12) | PDB UniProtKB/SwissProt DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 181 | n/a | n/a | n/a | n/a | n/a | 25 |
Merck Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ... | US Patent US9493441 (2016) BindingDB Entry DOI: 10.7270/Q22J69S2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Tyrosine-protein kinase JAK1 (Homo sapiens (Human)) | BDBM257478 (US9493441, 12-3) | PDB UniProtKB/SwissProt DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 245 | n/a | n/a | n/a | n/a | n/a | 25 |
Merck Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ... | US Patent US9493441 (2016) BindingDB Entry DOI: 10.7270/Q22J69S2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Tyrosine-protein kinase JAK1 (Homo sapiens (Human)) | BDBM257480 (US9493441, 12-5) | PDB UniProtKB/SwissProt DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 628 | n/a | n/a | n/a | n/a | n/a | 25 |
Merck Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ... | US Patent US9493441 (2016) BindingDB Entry DOI: 10.7270/Q22J69S2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Tyrosine-protein kinase JAK1 (Homo sapiens (Human)) | BDBM257498 (US9493441, 17-1) | PDB UniProtKB/SwissProt DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 224 | n/a | n/a | n/a | n/a | n/a | 25 |
Merck Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ... | US Patent US9493441 (2016) BindingDB Entry DOI: 10.7270/Q22J69S2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Tyrosine-protein kinase JAK2 (Homo sapiens (Human)) | BDBM257399 (US9493441, 1-10) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.48E+3 | n/a | n/a | n/a | n/a | n/a | 25 |
Merck Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ... | US Patent US9493441 (2016) BindingDB Entry DOI: 10.7270/Q22J69S2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Tyrosine-protein kinase JAK2 (Homo sapiens (Human)) | BDBM257429 (BDBM257439 | US9493441, 4-13) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 21 | n/a | n/a | n/a | n/a | n/a | 25 |
Merck Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ... | US Patent US9493441 (2016) BindingDB Entry DOI: 10.7270/Q22J69S2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Tyrosine-protein kinase JAK2 (Homo sapiens (Human)) | BDBM257451 (US9493441, 4-35) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 34 | n/a | n/a | n/a | n/a | n/a | 25 |
Merck Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ... | US Patent US9493441 (2016) BindingDB Entry DOI: 10.7270/Q22J69S2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Tyrosine-protein kinase JAK2 (Homo sapiens (Human)) | BDBM257469 (US9493441, 11-7) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 425 | n/a | n/a | n/a | n/a | n/a | 25 |
Merck Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ... | US Patent US9493441 (2016) BindingDB Entry DOI: 10.7270/Q22J69S2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Tyrosine-protein kinase JAK2 (Homo sapiens (Human)) | BDBM257481 (US9493441, 12-6) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | n/a | 25 |
Merck Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ... | US Patent US9493441 (2016) BindingDB Entry DOI: 10.7270/Q22J69S2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Tyrosine-protein kinase JAK1 (Homo sapiens (Human)) | BDBM257429 (BDBM257439 | US9493441, 4-13) | PDB UniProtKB/SwissProt DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | 25 |
Merck Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ... | US Patent US9493441 (2016) BindingDB Entry DOI: 10.7270/Q22J69S2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Tyrosine-protein kinase JAK1 (Homo sapiens (Human)) | BDBM257435 (US9493441, 4-19) | PDB UniProtKB/SwissProt DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | 25 |
Merck Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ... | US Patent US9493441 (2016) BindingDB Entry DOI: 10.7270/Q22J69S2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Tyrosine-protein kinase JAK1 (Homo sapiens (Human)) | BDBM257441 (US9493441, 4-25) | PDB UniProtKB/SwissProt DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 42 | n/a | n/a | n/a | n/a | n/a | 25 |
Merck Sharp & Dohme Corp. US Patent | Assay Description The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ... | US Patent US9493441 (2016) BindingDB Entry DOI: 10.7270/Q22J69S2 | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 222 total ) | Next | Last >> |